Argan director exercises options for 6,000 shares

ARGAN INC director Jeffrey John Ronald Jr. reported exercising stock options to acquire a total of 6,000 shares of common stock on June 30, 2026.

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

ARGAN INC director Jeffrey John Ronald Jr. reported exercising stock options to acquire a total of 6,000 shares of common stock on June 30, 2026. He exercised 5,000 options granted on December 16, 2022 at $35.72 per share and 1,000 options granted on December 14, 2023 at $43.70 per share, both using the net settle method.

Following these exercises, his direct ownership in ARGAN common stock increased to 8,249 shares. In addition, 8,000 shares are held indirectly through an account described as "John R. Jeffrey, IRA." The filing shows no open-market purchases or sales; all reported activity reflects option exercises.

Insider Trade Summary

6,000 shares exercised/converted

Exercise 5 txns

Insider Jeffrey John Ronald Jr.

Role Director

Type	Security	Shares	Price	Value
Exercise	Option to Purchase Common Stock	5,000	$35.72	$179K
Exercise	Option to Purchase Common Stock	1,000	$43.70	$44K
Exercise	Common Stock	4,772	$35.72	$170K
Exercise	Common Stock	944	$43.70	$41K
holding	Common Stock	--	--	--

Holdings After Transaction: Option to Purchase Common Stock — 2,000 contracts (Direct); Common Stock — 8,249 shares (Direct); Common Stock — 8,000 shares (Indirect, John R. Jeffrey, IRA)

Footnotes (2)

F1. On June 30, 2026, the Reporting Person exercised his stock option awarded on December 16, 2022 to purchase 5,000 shares of the Issuer's common stock at a price of $35.72 per share using the net settle method.
F2. On June 30, 2026, the Reporting Person exercised a portion of his stock option awarded on December 14, 2023 to purchase 1,000 shares of the Issuer's common stock at a price of $43.70 per share using the net settle method.

Key Figures

Options exercised at $35.72: 5,000 shares at $35.72/share Options exercised at $43.70: 1,000 shares at $43.70/share Total shares acquired via exercise: 6,000 shares +4 more

7 metrics

Options exercised at $35.72 5,000 shares at $35.72/share Stock option award dated December 16, 2022

Options exercised at $43.70 1,000 shares at $43.70/share Stock option award dated December 14, 2023

Total shares acquired via exercise 6,000 shares Option exercises on June 30, 2026

Direct common shares after transactions 8,249 shares Direct ownership following June 30, 2026 exercises

Indirect IRA-held shares 8,000 shares Held through "John R. Jeffrey, IRA" as of June 30, 2026

Remaining options from 2022 grant 1,500 options Option to purchase common stock after 5,000 exercised

Remaining options from 2023 grant 500 options Option to purchase common stock after 1,000 exercised

Key Terms

net settle method, stock option, Option to Purchase Common Stock, indirect ownership, +1 more

5 terms

net settle method financial

"to purchase 5,000 shares of the Issuer's common stock at a price of $35.72 per share using the net settle method."

stock option financial

"the Reporting Person exercised his stock option awarded on December 16, 2022 to purchase 5,000 shares"

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

Option to Purchase Common Stock financial

"security_title": "Option to Purchase Common Stock""

indirect ownership financial

"direct_or_indirect": "I", "nature_of_ownership": "John R. Jeffrey, IRA""

derivative exercise/conversion financial

"transaction_action": "derivative exercise/conversion""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider activity did Argan (AGX) director Jeffrey John Ronald Jr. report?

He reported exercising stock options to acquire 6,000 Argan shares. The exercises covered 5,000 options at $35.72 and 1,000 options at $43.70 per share, both on June 30, 2026, using the net settle method with no open-market trades disclosed.

How many Argan (AGX) shares does Jeffrey John Ronald Jr. hold after these transactions?

After the option exercises, he directly holds 8,249 Argan common shares. The filing also lists 8,000 shares held indirectly through an account labeled “John R. Jeffrey, IRA,” indicating both direct and IRA-based positions in the company’s stock.

Were any Argan (AGX) shares sold in this Form 4 filing?

No shares were reported sold in this Form 4. All reported transactions are option exercises coded “M,” which convert derivative awards into common stock. The transaction summary shows zero shares sold and no tax-withholding or gift dispositions.

What stock option grants did the Argan (AGX) director exercise?

He exercised 5,000 options from an award dated December 16, 2022 at $35.72 per share. He also exercised 1,000 options from a December 14, 2023 award at $43.70 per share, both described as using the net settle method.

What does “net settle method” mean in the Argan (AGX) Form 4 footnotes?

The filing states both option exercises used the net settle method. This indicates the option exercise was structured so that only net shares, after covering exercise costs or similar amounts, were delivered, rather than paying the full exercise price in cash.

Does the Argan (AGX) Form 4 show remaining stock options for the director?

Yes, the derivative tables show remaining options after exercise. One option grant shows 1,500 options remaining following a 5,000-share exercise, and another shows 500 options remaining after a 1,000-share exercise, both tied to ARGAN common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 07/02/2026 - 04:30 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Jeffrey John Ronald Jr.

(Last)

(First)

(Middle)

C/O ARGAN, INC.

4075 WILSON BOULEVARD, SUITE 440

(Street)

ARLINGTON

VIRGINIA

22203

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ARGAN INC [ AGX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	06/30/2026		M		4,772⁽¹⁾	A	$35.72	7,305	D
Common Stock	06/30/2026		M		944⁽²⁾	A	$43.7	8,249	D
Common Stock								8,000	I	John R. Jeffrey, IRA

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Option to Purchase Common Stock	$35.72	06/30/2026		M			5,000⁽¹⁾	12/16/2023	12/16/2032	Common Stock	5,000	$35.72	1,500	D
Option to Purchase Common Stock	$43.7	06/30/2026		M			1,000⁽²⁾	12/14/2024	12/14/2033	Common Stock	1,000	$43.7	500	D

Explanation of Responses:

1. On June 30, 2026, the Reporting Person exercised his stock option awarded on December 16, 2022 to purchase 5,000 shares of the Issuer's common stock at a price of $35.72 per share using the net settle method.

2. On June 30, 2026, the Reporting Person exercised a portion of his stock option awarded on December 14, 2023 to purchase 1,000 shares of the Issuer's common stock at a price of $43.70 per share using the net settle method.

	/s/ John R. Jeffrey, Jr.	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR